These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 17589770

  • 1. Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.S.
    White EF, Garfein RS, Brouwer KC, Lozada R, Ramos R, Firestone-Cruz M, Pérez SG, Magis-Rodríguez C, Conde-Glez CJ, Strathdee SA.
    Salud Publica Mex; 2007; 49(3):165-72. PubMed ID: 17589770
    [Abstract] [Full Text] [Related]

  • 2. Respondent-driven sampling of injection drug users in two U.S.-Mexico border cities: recruitment dynamics and impact on estimates of HIV and syphilis prevalence.
    Frost SD, Brouwer KC, Firestone Cruz MA, Ramos R, Ramos ME, Lozada RM, Magis-Rodriguez C, Strathdee SA.
    J Urban Health; 2006 Nov; 83(6 Suppl):i83-97. PubMed ID: 17072761
    [Abstract] [Full Text] [Related]

  • 3. Barriers and missed opportunities to HIV testing among injection drug users in two Mexico--US border cities.
    Moyer LB, Brouwer KC, Brodine SK, Ramos R, Lozada R, Cruz MF, Magis-Rodriguez C, Strathdee SA.
    Drug Alcohol Rev; 2008 Jan; 27(1):39-45. PubMed ID: 18034380
    [Abstract] [Full Text] [Related]

  • 4. HCV infection prevalence lower than expected among 18-40-year-old injection drug users in San Diego, CA.
    Garfein RS, Rondinelli A, Barnes RF, Cuevas J, Metzner M, Velasquez M, Rodriguez D, Reilly M, Xing J, Teshale EH.
    J Urban Health; 2013 Jun; 90(3):516-28. PubMed ID: 22766605
    [Abstract] [Full Text] [Related]

  • 5. Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities.
    Volkow P, Brouwer KC, Loza O, Ramos R, Lozada R, Garfein RS, Magis-Rodriguez C, Firestone-Cruz M, Strathdee SA.
    Int J Drug Policy; 2009 Sep; 20(5):409-12. PubMed ID: 19230645
    [Abstract] [Full Text] [Related]

  • 6. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G, National HIV Behavioral Surveillance System Study Group.
    MMWR Surveill Summ; 2014 Jul 04; 63(6):1-51. PubMed ID: 24990587
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk behaviors, prevalence of HIV and hepatitis C virus infection and population size of current injection drug users in a China-Myanmar border city: results from a Respondent-Driven Sampling Survey in 2012.
    Li L, Assanangkornchai S, Duo L, McNeil E, Li J.
    PLoS One; 2014 Jul 04; 9(9):e106899. PubMed ID: 25203256
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN.
    Clin Infect Dis; 2008 Jun 01; 46(11):1761-8. PubMed ID: 18433337
    [Abstract] [Full Text] [Related]

  • 12. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T, Platt L, Judd A, Mikhailova LA, Sarang A, Wallis N, Alpatova T, Hickman M, Parry JV.
    Int J STD AIDS; 2005 Nov 01; 16(11):749-54. PubMed ID: 16303071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities.
    Deiss RG, Brouwer KC, Loza O, Lozada RM, Ramos R, Cruz MA, Patterson TL, Heckathorn DD, Frost SD, Strathdee SA.
    Sex Transm Dis; 2008 Mar 01; 35(3):243-9. PubMed ID: 18046263
    [Abstract] [Full Text] [Related]

  • 15. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
    Panda S, Roy T, Pahari S, Mehraa J, Sharma N, Singh G, Singh J, Joseph F, Singh S, Sharma NM.
    Int J STD AIDS; 2014 Jul 01; 25(8):596-606. PubMed ID: 24352120
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.
    Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, Anand S, Kumar MS, Latkin C, Solomon S, Celentano DD.
    J Acquir Immune Defic Syndr; 2008 Nov 01; 49(3):327-32. PubMed ID: 18845962
    [Abstract] [Full Text] [Related]

  • 17. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS, Brajachand N, Singh HL, Singh YM.
    J Commun Dis; 2005 Mar 01; 37(1):73-7. PubMed ID: 16637404
    [Abstract] [Full Text] [Related]

  • 18. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y, Liu Y, Zou X, Chen W, Ling L.
    BMJ Open; 2017 Jul 13; 7(7):e015524. PubMed ID: 28710214
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Improving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.
    Judd A, Rhodes T, Johnston LG, Platt L, Andjelkovic V, Simić D, Mugosa B, Simić M, Zerjav S, Parry RP, Parry JV.
    BMC Infect Dis; 2009 Feb 09; 9():14. PubMed ID: 19203380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.